As the President and CEO of Bio-Techne, Kim Kelderman leverages her extensive experience in the highly regulated fields of Medical Devices and Life Sciences to drive innovation and growth within the organization. With a proven track record in managing complex product development processes, Kim has...
As the President and CEO of Bio-Techne, Kim Kelderman leverages her extensive experience in the highly regulated fields of Medical Devices and Life Sciences to drive innovation and growth within the organization. With a proven track record in managing complex product development processes, Kim has been instrumental in advancing Bio-Techne’s mission to empower researchers in Life Science and Clinical Diagnostics. Under her leadership, the company has focused on enhancing its portfolio of high-quality reagents, instruments, and custom manufacturing services, ensuring that researchers have access to the tools they need for reproducible results.
Kim's expertise in cross-functional team leadership and international sales has enabled Bio-Techne to expand its global footprint, fostering collaborations that enhance product offerings and market development. Her commitment to adhering to Good Manufacturing Practices (GMP) and navigating the intricacies of U.S. Food and Drug Administration (FDA) regulations has positioned Bio-Techne as a trusted partner in the medical device and analytical instrumentation sectors.
Key projects under Kim’s direction include the development of innovative diagnostic tools and advanced analytical instruments that cater to the evolving needs of the life sciences community. By fostering an entrepreneurial spirit within the organization, she has catalyzed positive change, driving Bio-Techne to not only meet but exceed industry standards. Kim’s competitive nature and passion for science fuel her vision for the future, as she continues to lead Bio-Techne in delivering award-winning solutions that empower researchers worldwide.
